OMED

OncoMed Pharmaceuticals, Inc.
OMED

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

OMED was delisted on the 22nd of April, 2019.

Back to rankings

53 hedge funds and large institutions have $66.3M invested in OncoMed Pharmaceuticals, Inc. in 2013 Q3 according to their latest regulatory filings, with 53 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$16.2M
2
+$6M
3
+$4.14M
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$4.12M
5
Primecap Management
Primecap Management
California
+$3.75M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$16.2M
2
$6M
3
$4.14M
4
$4.12M
5
$3.75M
6
$3.35M
7
$2.97M
8
$2.5M
9
$2.01M
10
$1.91M
11
$1.78M
12
$1.53M
13
$1.53M
14
$1.49M
15
$1.49M
16
$1.16M
17
$1.07M
18
$1.02M
19
$990K
20
$731K
21
$696K
22
$595K
23
$508K
24
$477K
25
$439K
1
2 3